A recent study indicates that a history of cesarean delivery is associated with a higher risk of developing postmolar gestational trophoblastic neoplasia. The retrospective cohort study, conducted across two reference centers, analyzed records of patients with histopathologically confirmed hydatidiform mole.
Investigators found that among 2,904 patients, prior cesarean delivery was independently linked to this elevated risk. Even after adjusting for crucial factors like age, mole histology, and pre-evacuation hCG levels, the association remained significant. The data suggests a history of cesarean delivery correlates with an estimated 45% increase in the odds of postmolar gestational trophoblastic neoplasia.
Importantly, the study found no clear signal for increased chemoresistance in patients with a prior cesarean delivery history. This means that while the risk of developing the neoplasia is higher, the tumors do not appear to be more resistant to standard chemotherapy treatments.
These findings underscore the importance of meticulous postmolar surveillance. While current management protocols can continue, the research suggests patients with a prior cesarean delivery may require heightened clinical vigilance within standard follow-up pathways due to the identified increased risk.